These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10853714)

  • 21. Body composition modulates the effects of hormone replacement therapy on growth hormone and insulin-like growth factor-I levels in postmenopausal women.
    Figueroa A; Going SB; Milliken LA; Blew R; Sharp S; Lohman TG
    Gynecol Obstet Invest; 2002; 54(4):201-6. PubMed ID: 12592062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beneficial effects of one-year growth hormone administration to children with juvenile chronic arthritis on chronic steroid therapy. I. Effects on growth velocity and body composition.
    Touati G; Prieur AM; Ruiz JC; Noel M; Czernichow P
    J Clin Endocrinol Metab; 1998 Feb; 83(2):403-9. PubMed ID: 9467548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone replacement therapy in the elderly with hypothalamic-pituitary disease: a dose-finding study.
    Toogood AA; Shalet SM
    J Clin Endocrinol Metab; 1999 Jan; 84(1):131-6. PubMed ID: 9920073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Body composition analysis by dual energy x-ray absorptiometry and anthropometry in adults with childhood-onset growth hormone (GH) deficiency before and after six months of recombinant GH therapy.
    Sartorio A; Narici M; Conti A; Giambona S; Ortolani S; Faglia G
    J Endocrinol Invest; 1997; 20(7):417-23. PubMed ID: 9309541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients.
    Attanasio AF; Shavrikova E; Blum WF; Cromer M; Child CJ; Paskova M; Lebl J; Chipman JJ; Shalet SM;
    J Clin Endocrinol Metab; 2004 Oct; 89(10):4857-62. PubMed ID: 15472176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.
    de Lind van Wijngaarden RF; Siemensma EP; Festen DA; Otten BJ; van Mil EG; Rotteveel J; Odink RJ; Bindels-de Heus GC; van Leeuwen M; Haring DA; Bocca G; Houdijk EC; Hoorweg-Nijman JJ; Vreuls RC; Jira PE; van Trotsenburg AS; Bakker B; Schroor EJ; Pilon JW; Wit JM; Drop SL; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4205-15. PubMed ID: 19837938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation.
    Lo JC; Mulligan K; Noor MA; Schwarz JM; Halvorsen RA; Grunfeld C; Schambelan M
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3480-7. PubMed ID: 11502767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone density and body composition in children with growth hormone insensitivity syndrome receiving recombinant IGF-I.
    Shaw NJ; Fraser NC; Rose S; Crabtree NJ; Boivin CM
    Clin Endocrinol (Oxf); 2003 Oct; 59(4):487-91. PubMed ID: 14510912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender-specific responses of lean body composition and non-gender-specific cardiac function improvement after GH replacement in GH-deficient adults.
    Ezzat S; Fear S; Gaillard RC; Gayle C; Landy H; Marcovitz S; Mattioni T; Nussey S; Rees A; Svanberg E
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2725-33. PubMed ID: 12050241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
    Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of growth hormone (GH) on glycerol and free fatty acid metabolism during exhaustive exercise in GH-deficient adults.
    Gibney J; Healy ML; Stolinski M; Bowes SB; Pentecost C; Breen L; McMillan C; Russell-Jones DL; Sonksen PH; Umpleby AM
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1792-7. PubMed ID: 12679475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients.
    Attanasio AF; Howell S; Bates PC; Frewer P; Chipman J; Blum WF; Shalet SM
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3368-72. PubMed ID: 12107251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant human insulin-like growth factor I has significant anabolic effects in adults with growth hormone receptor deficiency: studies on protein, glucose, and lipid metabolism.
    Mauras N; Martinez V; Rini A; Guevara-Aguirre J
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3036-42. PubMed ID: 10999782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in insulin sensitivity induced by short-term growth hormone (GH) and insulin-like growth factor I (IGF-I) treatment in GH-deficient adults are not associated with changes in adiponectin levels.
    Schmid C; Bianda T; Zwimpfer C; Zapf J; Wiesli P
    Growth Horm IGF Res; 2005 Aug; 15(4):300-3. PubMed ID: 16054413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two years of treatment with recombinant human growth hormone increases bone mineral density in men with idiopathic osteoporosis.
    Gillberg P; Mallmin H; Petrén-Mallmin M; Ljunghall S; Nilsson AG
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4900-6. PubMed ID: 12414848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial.
    Hoffman AR; Kuntze JE; Baptista J; Baum HB; Baumann GP; Biller BM; Clark RV; Cook D; Inzucchi SE; Kleinberg D; Klibanski A; Phillips LS; Ridgway EC; Robbins RJ; Schlechte J; Sharma M; Thorner MO; Vance ML
    J Clin Endocrinol Metab; 2004 May; 89(5):2048-56. PubMed ID: 15126520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One year of growth hormone treatment in adults with Prader-Willi syndrome improves body composition: results from a randomized, placebo-controlled study.
    Sode-Carlsen R; Farholt S; Rabben KF; Bollerslev J; Schreiner T; Jurik AG; Christiansen JS; Höybye C
    J Clin Endocrinol Metab; 2010 Nov; 95(11):4943-50. PubMed ID: 20702523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GH and IGF-I deficiency are associated with reduced loss of fat mass after laparoscopic-adjustable silicone gastric banding.
    Di Somma C; Angrisani L; Rota F; Savanelli MC; Cascella T; Belfiore A; Orio F; Lombardi G; Colao A; Savastano S
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):393-9. PubMed ID: 18194484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender.
    Johannsson G; Bjarnason R; Bramnert M; Carlsson LM; Degerblad M; Manhem P; Rośen T; Thorén M; Bengtsson BA
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1575-81. PubMed ID: 8636370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.